Dr. Scott S. Tykodi

Dr. Zhao believes in providing the best cancer care through multidisciplinary, evidence-based — yet personalized — approaches. Dr. Zhao is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Familial Prostate Cancer.

John Paul Flores, MD, is a board-certified medical oncologist. He cares for patients with blood disorders and all forms of cancer.Dr. Flores takes the time to guide his patients on their wellness journey, listening to what they say, answering their questions and providing a path forward with hope. In this complex, fast-growing field where new treatments are approved for clinical use regularly, Dr. Flores relies on the expertise of a team of surgeons, pathologists, radiation oncologists and other colleagues to stay at the forefront of cancer treatment and to provide comprehensive, patient-centered care. Dr. Flores is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Clear Cell Sarcoma, Prostatectomy, and Splenectomy.

Paul Kozlowski, MD, is a board-certified urologist specializing in minimally invasive laparoscopic and robotic surgery for a variety of urologic conditions, including kidney and other urologic cancers, prostate disease and kidney stones (including complex stones). He is experienced with both robotic and radical prostatectomy; renal reconstructive surgery; and ureteropelvic junction obstruction (UPJ). Dr. Kozlowski also offers aquablation treatment for benign prostate hyperplasia (HPB).Dr. Kozlowski strives to put himself in the patient's chair so he can better understand and relieve their concerns and anxieties. He savors his time with his patients and works hard to earn their trust.Dr. Kozlowski is a member of the American Urological Association, Endourological Society and Western Section of the American Urologic Association. He is a Pfizer Scholar in Urology and an associate clinical professor at the University of Washington. Dr. Kozlowski is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Ureterocele, Renal Cell Carcinoma (RCC), Nephrectomy, and Reconstructive Urology Surgery.